Literature DB >> 33074473

Enhanced Fe3+ binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity.

Roger Gumbau-Brisa1,2, M Trisha C Ang1,2, Bruce E Holbein2, Matthias Bierenstiel3.   

Abstract

To tackle the rise of antibiotic resistant pathogenic microbes, iron withdrawal agents have shown considerable promise as antibiotic alternatives due to the microbes' irreplaceable metabolic need for the essential element iron. DIBI is a water-soluble, linear co-polymer functionalized with 3-hydroxy-pyridin-4-one (HPO) chelators that selectively and strongly bind iron(III) in biological environments. Compared to HPO congeners, DIBI has over 1000 times higher antimicrobial activity against a broad-spectrum of Gram-(+) and Gram-(-) bacteria including highly antibiotic resistant clinical isolates. Herein, we explain the enhanced antimicrobial activity of DIBI by a cooperativity effect of the linear co-polymer wrapping around three iron(III) centres. DIBI's structural and iron(III) binding properties were investigated by comparative experiments against HPO monomer and deferiprone using chemical and physical characterization methods with direct biological implications such as pH stability, reductive off-loading of bound iron(III), trans-membrane permeability, and competition experiments with vertebrate transferrin class iron carrier. The three iron(III) ions bound to DIBI are preferentially incorporated into a tris-bidentate chelates, which forces the linear backbone of the polymer to wrap around the complexes, as the bound iron was much less susceptible to dithionite reduction than the tris iron(III) complexes of HPO monomers and deferiprone. The results suggest a high degree of cooperativity of the polymer-bound HPO groups to effect a wrapping of the polymer backbone around the chelated iron, shielding the iron(III) centres from ready access by microbes. The structural effect of DIBI is compared to polymers containing 3-hydroxy-pyridin-4-one chelators that do not undergo this wrapping effect.

Entities:  

Keywords:  3-hydroxy-pyridin-4-one chelators; Antibiotic properties; Cooperativity; Functional polymer; Iron chelator; Iron coordination; Polymer analysis; Wrapping effect

Mesh:

Substances:

Year:  2020        PMID: 33074473     DOI: 10.1007/s10534-020-00253-1

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  26 in total

1.  Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs.

Authors:  P Gans; A Sabatini; A Vacca
Journal:  Talanta       Date:  1996-10       Impact factor: 6.057

Review 2.  Iron and infection.

Authors:  Tomas Ganz
Journal:  Int J Hematol       Date:  2017-11-16       Impact factor: 2.490

Review 3.  Antibiotic resistance.

Authors:  Marianne Frieri; Krishan Kumar; Anthony Boutin
Journal:  J Infect Public Health       Date:  2016-09-06       Impact factor: 3.718

4.  From small deferiprone to macromolecular micelles: Self-assembly enhances iron chelation.

Authors:  Xiaoli Huang; Di Lu; Yongmin Ma; Limei Zhang; Lina Wang; Jian Deng; Zheng Wang; Yanjun Zhao
Journal:  J Colloid Interface Sci       Date:  2018-08-25       Impact factor: 8.128

5.  Effect of trace iron levels and iron withdrawal by chelation on the growth of Candida albicans and Candida vini.

Authors:  Bruce E Holbein; Ramón Mira de Orduña
Journal:  FEMS Microbiol Lett       Date:  2010-03-19       Impact factor: 2.742

6.  The fenton activity of iron(III) in the presence of deferiprone.

Authors:  Lakshmi D Devanur; Hendrik Neubert; Robert C Hider
Journal:  J Pharm Sci       Date:  2008-04       Impact factor: 3.534

7.  Iron (III)-chelating resins. 3. Synthesis, iron (III)-chelating properties, and in vitro antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1H)-pyridinone ligands.

Authors:  M H Feng; L van der Does; A Bantjes
Journal:  J Med Chem       Date:  1993-09-17       Impact factor: 7.446

8.  DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity.

Authors:  M Trisha C Ang; Roger Gumbau-Brisa; David S Allan; Robert McDonald; Michael J Ferguson; Bruce E Holbein; Matthias Bierenstiel
Journal:  Medchemcomm       Date:  2018-06-18       Impact factor: 3.597

9.  Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro.

Authors:  Maria Del Carmen Parquet; Kimberley A Savage; David S Allan; Ross J Davidson; Bruce E Holbein
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

10.  Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.

Authors:  Choon-Mee Kim; Sung-Heui Shin
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

View more
  3 in total

1.  Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury.

Authors:  Christian Lehmann; Nazli Alizadeh-Tabrizi; Stefan Hall; Sufyan Faridi; Irene Euodia; Bruce Holbein; Juan Zhou; Valerie Chappe
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

2.  Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis.

Authors:  Christian Lehmann; Maral Aali; Juan Zhou; Bruce Holbein
Journal:  Life (Basel)       Date:  2021-01-14

Review 3.  Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.

Authors:  Bruce E Holbein; M Trisha C Ang; David S Allan; Wangxue Chen; Christian Lehmann
Journal:  Environ Chem Lett       Date:  2021-04-23       Impact factor: 9.027

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.